Persistence of left ventricular hypertrophy is associated with increased cardiovascular morbidity and mortality in hypertensive patients with lower achieved systolic pressure during antihypertensive treatment.

Okin, Peter M; Hille, Darcy A; Kjeldsen, Sverre E; Dahlöf, Björn; Devereux, Richard B

Okin, Peter M; Hille, Darcy A; Kjeldsen, Sverre E; Dahlöf, Björn; Devereux, Richard B.

Affiliation

Okin PM; Greenberg Division of Cardiology, Weill Cornell Medical College , New York , USA.

Blood Press ; 23(2): 71-80, 2014 Apr.

Article in En | MEDLINE | ID: mdl-23721506

Subject(s)

Antihypertensive Agents/therapeutic use; Atenolol/therapeutic use; Hypertension/drug therapy; Hypertension/pathology; Hypertrophy, Left Ventricular/pathology; Aged; Double-Blind Method; Electrocardiography; Female; Humans; Hypertension/mortality; Male; Prognosis; Prospective Studies; Systole; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Atenolol / Hypertrophy, Left Ventricular / Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Blood Press Journal subject: ANGIOLOGIA Year: 2014 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google